Lowering C-reactive protein with statins after an ischemic stroke avoids mortality and readmissions. A prospective cohort study.

Aims: A hypothetical benefit of statins after an ischemic stroke could be provided by their pleiotropic effects. Our aim is to test if statins are able to avoid mortality and readmissions of patients with ischemic stroke, by lowering their levels of not only LDL-cholesterol but also CRP.

Methods: A prospective cohort study was performed.